This bill authorizes pharmacists in New Jersey to dispense HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) without an individual prescription under specific conditions, including the completion of a training program approved by the State Board of Pharmacy. Pharmacists must ensure that patients are HIV-negative, provide counseling, and document the services in the pharmacy's record system. The bill also requires pharmacists to notify the patient's primary care provider about the dispensation of these medications. Additionally, it allows pharmacists to furnish a complete course of PEP to patients who may have been exposed to HIV within the last 72 hours, contingent upon meeting certain clinical criteria and conducting necessary counseling.

Furthermore, the bill mandates that health insurance contracts cover HIV PrEP and PEP provided by pharmacists without requiring prior authorization or step therapy. It specifies that coverage must be provided for at least one version of the medication without prior authorization if there are FDA-approved therapeutic equivalents. The legislation limits the supply of PrEP that can be provided without a prescription to a maximum of 60 days within a two-year period and prohibits health plans from restricting pharmacists from dispensing these medications. Overall, the bill aims to enhance access to HIV prevention medications while ensuring adherence to proper protocols and patient care.